Lineage-specific purification of neural stem/progenitor cells from differentiated mouse induced pluripotent stem cells

Masato Maruyama, Yuji Yamashita, Masahiko Kase, Stefan Trifonov, Tetsuo Sugimoto

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Since induced pluripotent stem (iPS) cells have differentiation potential into all three germ layer-derived tissues, efficient purification of target cells is required in many fields of iPS research. One useful strategy is isolation of desired cells from differentiated iPS cells by lineage-specific expression of a drug-resistance gene, followed by drug selection. With this strategy, we purified neural stem/ progenitor cells (NSCs), a good candidate source for regenerative therapy, from differentiated mouse iPS cells. We constructed a bicistronic expression vector simultaneously expressing blastici-din S resistance gene and DsRed under the control of tandem enhancer of a 257-base pair region of nestin second intron, an NSC-specific enhancer. This construct was efficiently inserted into the iPS genome by piggyBac transposon-mediated gene transfer, and the established subclone was differentiated into NSCs in the presence or absence of blasticidin S. Consequently, incubation with blas-ticidin S led to purification of NSCs from differentiated iPS cells. Our results suggest that a lineage-specific drug selection strategy is useful for purification of NSCs from differentiated iPS cells and that this strategy can be applied for the purification of other cell types.

Original languageEnglish
Pages (from-to)420-433
Number of pages14
JournalStem Cells Translational Medicine
Volume2
Issue number6
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Neural Stem Cells
Stem Cells
Genes
Germ Layers
Nestin
Cell Separation
Cell Lineage
Drug Resistance
Base Pairing
Pharmaceutical Preparations
Introns
Cell Differentiation
Genome
Research

Keywords

  • Induced pluripotent stem cells
  • Neural differentiation
  • Neural stem cell
  • Stem/progenitor cell

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Lineage-specific purification of neural stem/progenitor cells from differentiated mouse induced pluripotent stem cells. / Maruyama, Masato; Yamashita, Yuji; Kase, Masahiko; Trifonov, Stefan; Sugimoto, Tetsuo.

In: Stem Cells Translational Medicine, Vol. 2, No. 6, 2013, p. 420-433.

Research output: Contribution to journalArticle

Maruyama, Masato ; Yamashita, Yuji ; Kase, Masahiko ; Trifonov, Stefan ; Sugimoto, Tetsuo. / Lineage-specific purification of neural stem/progenitor cells from differentiated mouse induced pluripotent stem cells. In: Stem Cells Translational Medicine. 2013 ; Vol. 2, No. 6. pp. 420-433.
@article{8ab8c0bfb5024da193ccff6fa780d9d7,
title = "Lineage-specific purification of neural stem/progenitor cells from differentiated mouse induced pluripotent stem cells",
abstract = "Since induced pluripotent stem (iPS) cells have differentiation potential into all three germ layer-derived tissues, efficient purification of target cells is required in many fields of iPS research. One useful strategy is isolation of desired cells from differentiated iPS cells by lineage-specific expression of a drug-resistance gene, followed by drug selection. With this strategy, we purified neural stem/ progenitor cells (NSCs), a good candidate source for regenerative therapy, from differentiated mouse iPS cells. We constructed a bicistronic expression vector simultaneously expressing blastici-din S resistance gene and DsRed under the control of tandem enhancer of a 257-base pair region of nestin second intron, an NSC-specific enhancer. This construct was efficiently inserted into the iPS genome by piggyBac transposon-mediated gene transfer, and the established subclone was differentiated into NSCs in the presence or absence of blasticidin S. Consequently, incubation with blas-ticidin S led to purification of NSCs from differentiated iPS cells. Our results suggest that a lineage-specific drug selection strategy is useful for purification of NSCs from differentiated iPS cells and that this strategy can be applied for the purification of other cell types.",
keywords = "Induced pluripotent stem cells, Neural differentiation, Neural stem cell, Stem/progenitor cell",
author = "Masato Maruyama and Yuji Yamashita and Masahiko Kase and Stefan Trifonov and Tetsuo Sugimoto",
year = "2013",
doi = "10.5966/sctm.2012-0139",
language = "English",
volume = "2",
pages = "420--433",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "6",

}

TY - JOUR

T1 - Lineage-specific purification of neural stem/progenitor cells from differentiated mouse induced pluripotent stem cells

AU - Maruyama, Masato

AU - Yamashita, Yuji

AU - Kase, Masahiko

AU - Trifonov, Stefan

AU - Sugimoto, Tetsuo

PY - 2013

Y1 - 2013

N2 - Since induced pluripotent stem (iPS) cells have differentiation potential into all three germ layer-derived tissues, efficient purification of target cells is required in many fields of iPS research. One useful strategy is isolation of desired cells from differentiated iPS cells by lineage-specific expression of a drug-resistance gene, followed by drug selection. With this strategy, we purified neural stem/ progenitor cells (NSCs), a good candidate source for regenerative therapy, from differentiated mouse iPS cells. We constructed a bicistronic expression vector simultaneously expressing blastici-din S resistance gene and DsRed under the control of tandem enhancer of a 257-base pair region of nestin second intron, an NSC-specific enhancer. This construct was efficiently inserted into the iPS genome by piggyBac transposon-mediated gene transfer, and the established subclone was differentiated into NSCs in the presence or absence of blasticidin S. Consequently, incubation with blas-ticidin S led to purification of NSCs from differentiated iPS cells. Our results suggest that a lineage-specific drug selection strategy is useful for purification of NSCs from differentiated iPS cells and that this strategy can be applied for the purification of other cell types.

AB - Since induced pluripotent stem (iPS) cells have differentiation potential into all three germ layer-derived tissues, efficient purification of target cells is required in many fields of iPS research. One useful strategy is isolation of desired cells from differentiated iPS cells by lineage-specific expression of a drug-resistance gene, followed by drug selection. With this strategy, we purified neural stem/ progenitor cells (NSCs), a good candidate source for regenerative therapy, from differentiated mouse iPS cells. We constructed a bicistronic expression vector simultaneously expressing blastici-din S resistance gene and DsRed under the control of tandem enhancer of a 257-base pair region of nestin second intron, an NSC-specific enhancer. This construct was efficiently inserted into the iPS genome by piggyBac transposon-mediated gene transfer, and the established subclone was differentiated into NSCs in the presence or absence of blasticidin S. Consequently, incubation with blas-ticidin S led to purification of NSCs from differentiated iPS cells. Our results suggest that a lineage-specific drug selection strategy is useful for purification of NSCs from differentiated iPS cells and that this strategy can be applied for the purification of other cell types.

KW - Induced pluripotent stem cells

KW - Neural differentiation

KW - Neural stem cell

KW - Stem/progenitor cell

UR - http://www.scopus.com/inward/record.url?scp=84878768475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878768475&partnerID=8YFLogxK

U2 - 10.5966/sctm.2012-0139

DO - 10.5966/sctm.2012-0139

M3 - Article

C2 - 23694811

AN - SCOPUS:84878768475

VL - 2

SP - 420

EP - 433

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 6

ER -